Role of human papillomavirus in the carcinogenesis of squamous cell carcinoma and adenocarcinoma of the cervix

被引:81
|
作者
Tjalma, WAA
Van Waes, TR
Van den Eeden, LEM
Bogers, JJPM
机构
[1] Univ Antwerp, Univ Antwerp Hosp, Dept Gynecol & Gynecol Oncol, B-2650 Antwerp, Belgium
[2] Univ Antwerp, Fac Med, Lab Cell & Tissue Res, B-2000 Antwerp, Belgium
关键词
cervical carcinogenesis; HPV; squamous cell carcinoma; adenocarcinoma;
D O I
10.1016/j.bpobgyn.2005.02.002
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Human papillomavirus (HPV) infection is the most common sexually transmitted disease, with more than 80% of the population infected at some time in their life. In rare cases, this infection may lead to cervical cancer. Virtually all squamous cell carcinomas and the overwhelming majority of adenocarcinomas of the cervix are HPV positive. HPV integration in the genome will lead to inactivation of the p53 pathway and the Rb pathway. Integration is essential for the onset of cervical carcinogenesis, but is probably not sufficient for progression to invasive cervical cancers. It is likely that several cofactors, such as environmental, viral and host-related factors, are necessary for the development of cervical cancer. There are several similarities and differences between the two major histological types. This article will address the role of HPV in cervical carcinogenesis as well as the molecular biology involved in the process.
引用
收藏
页码:469 / 483
页数:15
相关论文
共 50 条
  • [31] Squamous Cell Carcinoma of the Cervix A Cytology-Histology-Human Papillomavirus Correlation in Clinical Practice
    Miller, Ross A.
    Waters, Lindsay L.
    Mody, Dina R.
    Tams, Kimberlee C.
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (06) : 776 - 781
  • [32] Adenocarcinoma and Squamous Cell Carcinoma of the Cervix: Should They Be Treated Differently?
    Faustino, I.
    Catarino, R.
    Lombo, L.
    Figueiredo, T.
    Carvalho, L.
    Salgado, L.
    Sousa, S.
    Couto, R.
    Afonso, N.
    Pereira, D.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S531 - S532
  • [33] Human papillomavirus genomes in squamous cell carcinomas of the uterine cervix
    Matsukura, T
    Sugase, M
    [J]. VIROLOGY, 2004, 324 (02) : 439 - 449
  • [34] Should Adenocarcinoma of Cervix be Treated Differently to Squamous Cell Carcinoma?
    Lin, Ming Yin
    Rajasooriyar, Chrishanthi
    Kondalsamy-Chennakesavan, Srinivas
    Narayan, Kailash
    [J]. INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 19 (01)
  • [35] Frequency of high risk human papillomavirus types in squamous cell carcinoma of cervix among women
    Yousuf, Sadaf
    Syed, Serajuddaula
    Moazzam, Ambreen
    Lucky, Mohammad Haris
    [J]. JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2010, 60 (03) : 193 - 196
  • [36] Human papillomavirus infection in esophageal squamous cell carcinoma and esophageal adenocarcinoma: a concise review
    Rajendra, Shanmugarajah
    Pavey, Darren
    McKay, Owen
    Merrett, Neil
    Gautam, Shweta Dutta
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2020, 1482 (01) : 36 - 48
  • [37] ADENOCARCINOMA OF THE CERVIX ASSOCIATED WITH HUMAN PAPILLOMAVIRUS
    WILCZYNSKI, SP
    WALKER, J
    LIAO, SY
    BERGEN, S
    BERMAN, M
    [J]. CANCER, 1988, 62 (07) : 1331 - 1336
  • [38] The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma
    Daisuke Sano
    Nobuhiko Oridate
    [J]. International Journal of Clinical Oncology, 2016, 21 : 819 - 826
  • [39] The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma
    Sano, Daisuke
    Oridate, Nobuhiko
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (05) : 819 - 826
  • [40] Coexistent squamous cell carcinoma and adenoid basal carcinoma in the uterine cervix and infection with human papillomavirus (HPV 31)
    Lin, Yu-Chieh
    Perng, Cherng-Lih
    Chang, Yi-Ming
    Li, Yao-Feng
    Tsai, Yuan-Ming
    Wu, Gwo-Jang
    Lin, Chih-Kung
    [J]. TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2013, 52 (03): : 407 - 410